Methods of Treating Joint Diseases, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinases
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 62/140,909, filed Mar 31, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,433,918 | Methods of Treating Joint Disease, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinase In force · High confidence | Prime Merger Sub, LLC | In force | High confidence | ||
| US 10,576,107 | Methods of Treating Joint Diseases, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinases In force · High confidence | Prime Merger Sub, LLC | In force | High confidence | ||
| US 11,666,606 | Methods of Treating Joint Disease, Disorders and Conditions with Tissue Inhibitors of Matrix Metalloproteinases In force · Low confidence | Prime Merger Sub, LLC | In force | Low confidence |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.